David A. Scheinberg
CIK: 0001250316
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLS
SELLAS Life Sciences Group, Inc.
Director
Discretionary Trading P&L
Holdings
About SCHEINBERG DAVID A
SCHEINBERG DAVID A (SEC CIK 0001250316) files insider reports with the SEC as Director of SELLAS Life Sciences Group, Inc. (SLS).
Signal8 holds 2 ownership filings by SCHEINBERG DAVID A, all Form 4s, filed between Jan 14, 2025 and Jan 9, 2026. Those filings report 2 transactions, from Jan 10, 2025 to Jan 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SCHEINBERG DAVID A's filings is in NEW YORK, NY.
Recent filings by SCHEINBERG DAVID A
Other insiders filing for SELLAS Life Sciences Group, Inc. (SLS)
- Stergiou Angelos M., President and CEO
- Varian John, Director
- VAN NOSTRAND ROBERT L, Director
- CICIC DRAGAN, SVP, Chief Development Officer
- Burns John Thomas, CFO
- Kalin Katherine Bach, Director